Short communication · 8 May 2024
EditorialPublished 31 Mar 2021
Gene Technology in Parkinson's
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Parkinson's disease (PD) is a neurodegenerative disease that primarily affects the elderly, with a median onset age of 60 years. The precise cause of this pathological change is unknown at this time. Genetic factors, environmental factors, ageing, and oxidative stress may all play a role in the degeneration of dopaminergic neurons in Parkinson's disease.
Keywords
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 25 May 2018
Deep brain stimulation for advanced parkinson′s disease multicurrent and multiload electrodes technology
Editorial · 2016
Advanced Technology to Enhance Rehabilitation Outcomes: Parkinson Disease
Research article · 30 Jul 2024
Gene Therapy for Parkinson’s Disease: Targeting Dopamine Replacement and Cell Function Modulation
Commentary · 22 May 2024
Parkinsonism Gene Therapy: An Overview of Upcoming Developments
More from this journal
The newest in Journal of Alzheimers Disease & Parkinsonism.
Commentary · 8 Jun 2026
Cognitive Concerns: The Side Effects of Surgery in Alzheimer's Patients
Perspective · 8 Jun 2026
Oxidative Stress and Its Role in Neuronal Degeneration: Mechanisms and Implications
Commentary · 8 Jun 2026
Understanding the Pathophysiology of Prion-Induced Dementia
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Andrea Tales”
